DK0434094T3 - Fremgangsmåder til anvendelse af 2-isopropyl-2-phenylaminovaleronitriler som immunosuppressorer og vasodilatatorer - Google Patents

Fremgangsmåder til anvendelse af 2-isopropyl-2-phenylaminovaleronitriler som immunosuppressorer og vasodilatatorer

Info

Publication number
DK0434094T3
DK0434094T3 DK90125244.5T DK90125244T DK0434094T3 DK 0434094 T3 DK0434094 T3 DK 0434094T3 DK 90125244 T DK90125244 T DK 90125244T DK 0434094 T3 DK0434094 T3 DK 0434094T3
Authority
DK
Denmark
Prior art keywords
immunosuppressors
isopropyl
cyclosporin
phenylaminovaleronitriles
vasodilators
Prior art date
Application number
DK90125244.5T
Other languages
English (en)
Inventor
Richard Aug Mueller
Kearn John P Mc
Terry B Strom
Kenneth J Wieder
Liang Chi-Dean
Original Assignee
Searle & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Searle & Co filed Critical Searle & Co
Application granted granted Critical
Publication of DK0434094T3 publication Critical patent/DK0434094T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/32—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring
    • C07C255/42—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms
    • C07C255/43—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms having cyano groups bound to acyclic carbon atoms of a carbon skeleton containing at least one six-membered aromatic ring the carbon skeleton being further substituted by singly-bound nitrogen atoms, not being further bound to other hetero atoms the carbon skeleton being further substituted by singly-bound oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Transplantation (AREA)
  • Vascular Medicine (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK90125244.5T 1989-12-21 1990-12-21 Fremgangsmåder til anvendelse af 2-isopropyl-2-phenylaminovaleronitriler som immunosuppressorer og vasodilatatorer DK0434094T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45600789A 1989-12-21 1989-12-21

Publications (1)

Publication Number Publication Date
DK0434094T3 true DK0434094T3 (da) 1993-08-16

Family

ID=23811068

Family Applications (1)

Application Number Title Priority Date Filing Date
DK90125244.5T DK0434094T3 (da) 1989-12-21 1990-12-21 Fremgangsmåder til anvendelse af 2-isopropyl-2-phenylaminovaleronitriler som immunosuppressorer og vasodilatatorer

Country Status (10)

Country Link
EP (1) EP0434094B1 (da)
JP (1) JPH04210632A (da)
AT (1) ATE87614T1 (da)
CA (1) CA2033038A1 (da)
DE (1) DE69001240T2 (da)
DK (1) DK0434094T3 (da)
ES (1) ES2054207T3 (da)
GR (1) GR3008320T3 (da)
IE (1) IE64870B1 (da)
PT (1) PT96283A (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100190852A1 (en) 2007-06-20 2010-07-29 Milestone Pharmaceuticals Inc. Short acting phenylalkylamine calcium channel blockers and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3642331A1 (de) * 1986-12-11 1988-06-23 Basf Ag Basisch substituierte phenylacetonitrile, ihre herstellung und diese enthaltende arzneimittel

Also Published As

Publication number Publication date
EP0434094B1 (en) 1993-03-31
GR3008320T3 (da) 1993-09-30
DE69001240T2 (de) 1993-08-05
IE904627A1 (en) 1991-07-17
DE69001240D1 (de) 1993-05-06
ES2054207T3 (es) 1994-08-01
IE64870B1 (en) 1995-09-20
EP0434094A1 (en) 1991-06-26
PT96283A (pt) 1991-09-30
JPH04210632A (ja) 1992-07-31
ATE87614T1 (de) 1993-04-15
CA2033038A1 (en) 1991-06-22

Similar Documents

Publication Publication Date Title
DE69430951T2 (de) Zusammensetzung enthaltend bradykinin zum selektiven offnen von anormalen gehirngewebes kapillaren
DK0735890T3 (da) Blandinger af 2',3'-dideoxyinosin og hydroxycarbamid til hæmning af retroviral spredning
ATE105482T1 (de) Behandlung von krebs mit somatostatin und mit analogen davon.
DE68915834D1 (de) Herstellung von T-Zellen und T-Zellmembranen, verwendbar zur Verhütung und Behandlung von Autoimmunkrankheiten.
DK0387867T3 (da) Præparat indeholdende D-cycloserin og D-alanin til forbedring af hukommelse og indlæringsevne eller til behandling af en kognitiv eller psykotisk lidelse
DE69525151T2 (de) Methoden zur krankheitsbehandlung unter verwendung von sertoli-zellen und allotransplantat oder xenotransplantat
EE9700225A (et) Meetod diabetes mellituse raviks, kasutades KKF
DE69010162T2 (de) Zusammensetzung zur Behandlung von Entzündung.
DK71387A (da) Terapeutisk middel til behandling af psoriasis
DK0572688T3 (da) Peptider, med organ-beskyttende aktivitet, fremgangsmåde til deres fremstilling og deres anvendelse ved terapi
DE3480901D1 (de) Haarbehandlungsmittel.
ATE152621T1 (de) Behandlungsverfahren kataboler dysfunktion
ATE133663T1 (de) Antiglancoma-zusammensetzungen enthaltend 3- arylcarbonyl-1-aminoalkyl-1h-indol
DK502087A (da) Bindingsinducerende praeparat og fremgangsmaade til inducering af binding mellem dele af levende mineraliseret vaev
NO894222D0 (no) Fremgangsmaater for behandling av profylakse av pneumocytis carinii pneumoni og andre sykdommer og forbindelser og formuleringer til anvendelse i nevnte metoder.
IT1135158B (it) Procedimento di iniezione e di formazione della miscela,come pure dispositivo per la realizzazione dello stesso
DK472688D0 (da) Anvendelse af bezafibrat til behandling af diabetes
DK0434094T3 (da) Fremgangsmåder til anvendelse af 2-isopropyl-2-phenylaminovaleronitriler som immunosuppressorer og vasodilatatorer
NO20001758L (no) FremgangsmÕter og blandinger for behandling av leddgikt
DK0504307T3 (da) Fremgangsmåde til behandling af septisk shock
DK381085A (da) Fremgangsmaade og middel til bekaempelse af luseangreb
DE68916777D1 (de) Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis.
NO893224L (no) Fremgangsmaate for anrikning av vann med oksygen.
DK0458537T3 (da) Anvendelse af en terapeutisk forbindelse til behandling af bronkitis
ATE41927T1 (de) Phenylalkylamine - bioregulatoren.